(VIANEWS) – Healthcare Realty Trust Incorporated (HR), Iron Mountain Incorporated (IRM), Diageo (DEO) have the highest dividend yield stocks on this list.
| Financial Asset | Forward Dividend Yield | Updated (EST) |
|---|---|---|
| Healthcare Realty Trust Incorporated (HR) | 7.92% | 2024-05-28 23:15:06 |
| Iron Mountain Incorporated (IRM) | 3.24% | 2024-05-29 03:49:06 |
| Diageo (DEO) | 2.97% | 2024-06-09 03:12:40 |
| Merck (MRK) | 2.36% | 2024-06-09 03:18:12 |
Almost 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.
1. Healthcare Realty Trust Incorporated (HR) – Dividend Yield: 7.92%
Healthcare Realty Trust Incorporated’s last close was $15.69, 22.52% below its 52-week high of $20.25. Intraday change was 0.26%.
Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of September 30, 2020, the Company owned 211 real estate properties in 24 states totaling 15.5 million square feet and was valued at approximately $5.5 billion. The Company provided leasing and property management services to 11.9 million square feet nationwide.
Earnings Per Share
As for profitability, Healthcare Realty Trust Incorporated has a trailing twelve months EPS of $-1.33.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.29%.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 45.5% and 33.3%, respectively.
Yearly Top and Bottom Value
Healthcare Realty Trust Incorporated’s stock is valued at $15.69 at 17:15 EST, way under its 52-week high of $20.25 and way above its 52-week low of $12.77.
Sales Growth
Healthcare Realty Trust Incorporated’s sales growth is negative 1.7% for the present quarter and negative 4.5% for the next.
Moving Average
Healthcare Realty Trust Incorporated’s worth is above its 50-day moving average of $14.53 and higher than its 200-day moving average of $15.33.
More news about Healthcare Realty Trust Incorporated.
2. Iron Mountain Incorporated (IRM) – Dividend Yield: 3.24%
Iron Mountain Incorporated’s last close was $79.50, 4.22% below its 52-week high of $83.00. Intraday change was -0.91%.
Iron Mountain Incorporated (NYSE: IRM), founded in 1951, is the global leader for storage and information management services. Trusted by more than 225,000 organizations around the world, and with a real estate network of more than 90 million square feet across more than 1,480 facilities in approximately 50 countries, Iron Mountain stores and protects billions of valued assets, including critical business information, highly sensitive data, and cultural and historical artifacts. Providing solutions that include secure records storage, information management, digital transformation, secure destruction, as well as data centers, cloud services and art storage and logistics, Iron Mountain helps customers lower cost and risk, comply with regulations, recover from disaster, and enable a more digital way of working.
Earnings Per Share
As for profitability, Iron Mountain Incorporated has a trailing twelve months EPS of $0.65.
PE Ratio
Iron Mountain Incorporated has a trailing twelve months price to earnings ratio of 122.31. Meaning, the purchaser of the share is investing $122.31 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 47.37%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.4%, now sitting on 5.64B for the twelve trailing months.
Sales Growth
Iron Mountain Incorporated’s sales growth is 10.8% for the present quarter and 9.2% for the next.
More news about Iron Mountain Incorporated.
3. Diageo (DEO) – Dividend Yield: 2.97%
Diageo’s last close was $133.37, 25.81% under its 52-week high of $179.78. Intraday change was -2.75%.
Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. It offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavoured malt beverages. The company also provides Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as ready to drink and non-alcoholic products. It provides its products primarily under the Johnnie Walker, Guinness, Tanqueray, Baileys, Smirnoff, Captain Morgan, Crown Royal, Don Julio, Cîroc, Buchanan's, Casamigos, J&B, and Ketel One brands. The company operates in the United States, the United Kingdom, Turkey, Australia, Korea, India, Greater China, Brazil, Mexico, South Africa, Nigeria, and internationally. Diageo plc was incorporated in 1886 and is headquartered in London, the United Kingdom.
Earnings Per Share
As for profitability, Diageo has a trailing twelve months EPS of $7.48.
PE Ratio
Diageo has a trailing twelve months price to earnings ratio of 18.31. Meaning, the purchaser of the share is investing $18.31 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 36.41%.
Volume
Today’s last reported volume for Diageo is 765781 which is 0.18% above its average volume of 764331.
Yearly Top and Bottom Value
Diageo’s stock is valued at $136.99 at 17:15 EST, way under its 52-week high of $179.78 and higher than its 52-week low of $131.43.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Feb 29, 2024, the estimated forward annual dividend rate is 4.01 and the estimated forward annual dividend yield is 2.97%.
Moving Average
Diageo’s value is below its 50-day moving average of $141.05 and under its 200-day moving average of $147.76.
More news about Diageo.
4. Merck (MRK) – Dividend Yield: 2.36%
Merck’s last close was $130.20, 2.18% under its 52-week high of $133.10. Intraday change was -0.33%.
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes under the Keytruda, Bridion, Adempas, Lagevrio, Belsomra, Simponi, and Januvia brands, as well as vaccine products consisting of preventive pediatric, adolescent, and adult vaccines under the Gardasil/Gardasil 9, ProQuad, M-M-R II, Varivax, RotaTeq, Live Oral, Vaxneuvance, Pneumovax 23, and Vaqta names. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians, wholesalers, government entities, veterinarians, distributors, animal producers, farmers, and pet owners. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates, which include patritumab deruxtecan, ifinatamab deruxtecan, and raludotatug deruxtecan for the treatment of multiple solid tumors both as monotherapy and/or in combination with other treatments; and AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications. The company also has a collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Earnings Per Share
As for profitability, Merck has a trailing twelve months EPS of $0.14.
PE Ratio
Merck has a trailing twelve months price to earnings ratio of 898.14. Meaning, the purchaser of the share is investing $898.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.31%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 8.9%, now sitting on 61.4B for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 203.9% and 20.6%, respectively.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Jun 17, 2024, the estimated forward annual dividend rate is 3.08 and the estimated forward annual dividend yield is 2.36%.
Previous days news about Merck
- Merck (mrk) stock moves 0.27%: what you should know. According to Zacks on Tuesday, 11 June, "Its industry sports an average Forward P/E of 14.5, so one might conclude that Merck is trading at a premium comparatively.", "In the latest trading session, Merck (MRK Quick QuoteMRK – Free Report) closed at $131.84, marking a +0.27% move from the previous day. "
More news about Merck.
